{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:58:05Z","timestamp":1791557885492,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11030-019-09940-9","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T11:02:57Z","timestamp":1553079777000},"page":"179-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluations"],"prefix":"10.1007","volume":"24","author":[{"given":"Arefeh","family":"Shafie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mohammadi-Khanaposhtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parviz Rashidi","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahan B.","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Shafaroodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"key":"9940_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(97)01514-8","volume":"342","author":"W L\u00f6scher","year":"1998","unstructured":"L\u00f6scher W (1998) New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 342:1\u201313. \nhttps:\/\/doi.org\/10.1016\/S0014-2999(97)01514-8","journal-title":"Eur J Pharmacol"},{"key":"9940_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4088\/JCP.v64n0107","volume":"64","author":"KJ Meador","year":"2003","unstructured":"Meador KJ (2003) Newer anticonvulsants: dosing strategies and cognition in treating patients with mood disorders and epilepsy. J Clin Psychiatry 64:30\u201334","journal-title":"J Clin Psychiatry"},{"key":"9940_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/(SICI)1098-1128(199711)17","volume":"17","author":"Z Lin","year":"1997","unstructured":"Lin Z, Kadaba PK (1997) Molecular targets for the rational design of antiepileptic drugs and related neuroprotective agents. Med Res Rev 17:537\u2013572. \nhttps:\/\/doi.org\/10.1002\/(SICI)1098-1128(199711)17","journal-title":"Med Res Rev"},{"key":"9940_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1600-0404.2008.01004.x","volume":"118","author":"J Riss","year":"2008","unstructured":"Riss J, Cloyd J, Gates J, Collins S (2008) Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand 118:69\u201386. \nhttps:\/\/doi.org\/10.1111\/j.1600-0404.2008.01004.x","journal-title":"Acta Neurol Scand"},{"key":"9940_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0024-3205(75)90501-9","volume":"17","author":"E Costa","year":"1975","unstructured":"Costa E, Guidotti A, Mao CC, Suria A (1975) New concepts on the mechanism of action of benzodiazepines. Life Sci 17:167\u2013185. \nhttps:\/\/doi.org\/10.1016\/0024-3205(75)90501-9","journal-title":"Life Sci"},{"key":"9940_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ejmech.2005.12.003","volume":"41","author":"B Narayana","year":"2006","unstructured":"Narayana B, Raj KV, Ashalatha BV, Kumari NS (2006) Synthesis of some new substituted triazolo[4,3-a][1,4]benzodiazepine derivatives as potent anticonvulsants. Eur J Med Chem 41:417\u2013422. \nhttps:\/\/doi.org\/10.1016\/j.ejmech.2005.12.003","journal-title":"Eur J Med Chem"},{"key":"9940_CR7","first-page":"13","volume":"51","author":"G Biagi","year":"1996","unstructured":"Biagi G, Giorgi I, Livi O, Scartoni V, Velo S, DeSantis B, Martinelli A, Martini C, Senatore G (1996) 1,2,3-Triazolo[1,5-a][1,3] benzodiazepine a new heterocyclic system: synthesis, benzodiazepine receptor binding and theoretical calculations. Il Farmaco 51:13\u201318","journal-title":"Il Farmaco"},{"key":"9940_CR8","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1016\/j.tet.2014.07.050","volume":"70","author":"K Hemming","year":"2014","unstructured":"Hemming K, Chambers CS, Hamasharif MS, Joao H, Khan MN, Patel N, Airley R, Day S (2014) Azide based routes to tetrazolo and oxadiazolo derivatives of pyrrolobenzodiazepines and pyrrolobenzothiadiazepines. Tetrahedron 70:7306\u20137317. \nhttps:\/\/doi.org\/10.1016\/j.tet.2014.07.050","journal-title":"Tetrahedron"},{"key":"9940_CR9","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1016\/j.bmcl.2009.06.107","volume":"19","author":"DK Mohapatra","year":"2009","unstructured":"Mohapatra DK, Maity PK, Shabab M, Khan MI (2009) Click chemistry based rapid one-pot synthesis and evaluation for protease inhibition of new tetracyclic triazole fused benzodiazepine derivatives. Bioorg Med Chem Lett 19:5241\u20135245. \nhttps:\/\/doi.org\/10.1016\/j.bmcl.2009.06.107","journal-title":"Bioorg Med Chem Lett"},{"key":"9940_CR10","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1016\/j.tet.2013.02.023","volume":"69","author":"M Saeedi","year":"2013","unstructured":"Saeedi M, Mahdavi M, Foroumadi A, Shafiee A (2013) Synthesis of novel fused 4,5-dihydro-1,2,3-triazolo[1,5-a][1,4]benzodiazepine derivatives via four-component Ugi\u2013Smiles-type reaction. Tetrahedron 69:3506\u20133510. \nhttps:\/\/doi.org\/10.1016\/j.tet.2013.02.023","journal-title":"Tetrahedron"},{"key":"9940_CR11","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1055\/s-0032-1317297","volume":"23","author":"M Mahdavi","year":"2012","unstructured":"Mahdavi M, Asadi M, Saeedi M, Rezaei Z, Moghbel H, Foroumadi A, Shafiee A (2012) Synthesis of novel 1,4-benzodiazepine-3,5-dione derivatives: reaction of 2-aminobenzamides under Bargellini reaction conditions. Synlett 23:2521\u20132525. \nhttps:\/\/doi.org\/10.1055\/s-0032-1317297","journal-title":"Synlett"},{"key":"9940_CR12","doi-asserted-by":"publisher","first-page":"6272","DOI":"10.1016\/j.tet.2015.06.060","volume":"71","author":"S Noushini","year":"2015","unstructured":"Noushini S, Mahdavi M, Firoozpour L, Moghimi S, Shafiee A, Foroumadi A (2015) Efficient multi-component synthesis of 1,4-benzodiazepine-3,5-diones: a Petasis-based approach. Tetrahedron 71:6272\u20136275. \nhttps:\/\/doi.org\/10.1016\/j.tet.2015.06.060","journal-title":"Tetrahedron"},{"key":"9940_CR13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/ol1028404","volume":"13","author":"JR Donald","year":"2011","unstructured":"Donald JR, Martin SF (2011) Synthesis and diversification of 1,2,3-triazole-fused 1,4-benzodiazepine scaffolds. Org Lett 13:852\u2013855. \nhttps:\/\/doi.org\/10.1021\/ol1028404","journal-title":"Org Lett"},{"key":"9940_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2018.02.009","author":"A Oluwaseye","year":"2018","unstructured":"Oluwaseye A, Uzairu A, Shallangwa GA, Abechi SE (2018) Quantum chemical descriptors in the QSAR studies of compounds active in maxima electroshock seizure test. J King Saud Univ Sci. \nhttps:\/\/doi.org\/10.1016\/j.jksus.2018.02.009","journal-title":"J King Saud Univ Sci"},{"key":"9940_CR15","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1016\/j.ejmech.2010.02.063","volume":"45","author":"F Azam","year":"2010","unstructured":"Azam F, El-gnidi BA, Alkskas IA (2010) Combating oxidative stress in epilepsy: design, synthesis, quantum chemical studies and anticonvulsant evaluation of 1-(substituted benzylidene\/ethylidene)-4-(naphthalen-1-yl) semicarbazides. Eur J Med Chem 45:2817\u20132826. \nhttps:\/\/doi.org\/10.1016\/j.ejmech.2010.02.063","journal-title":"Eur J Med Chem"},{"key":"9940_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.farmac.2003.11.013","volume":"59","author":"L Navidpour","year":"2004","unstructured":"Navidpour L, Shafaroodi H, Miri R, Dehpour AR, Shafiee A (2004) Lipophilic 4-imidazoly-1,4-dihydropyridines: synthesis, calcium channel antagonist activity and protection against pentylenetetrazole-induced seizure. Il Farmaco 59:261\u2013269. \nhttps:\/\/doi.org\/10.1016\/j.farmac.2003.11.013","journal-title":"Il Farmaco"},{"key":"9940_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1179\/1743132812Y.0000000080","volume":"34","author":"H Shafaroodi","year":"2012","unstructured":"Shafaroodi H, Moezi L, Fakhrzad A, Hassanipour M, Rezayat M, Dehpour AR (2012) The involvement of nitric oxide in the anti-seizure effect of acute atorvastatin treatment in mice. Neurol Res 34:847\u2013853. \nhttps:\/\/doi.org\/10.1179\/1743132812Y.0000000080","journal-title":"Neurol Res"},{"key":"9940_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bioorg.2018.03.001","volume":"78","author":"L Dehestani","year":"2018","unstructured":"Dehestani L, Ahangar N, Hashemi SM, Irannejad H, Masihi PH, Shakiba A, Emami S (2018) Design, synthesis, in vivo and in silico evaluation of phenacyl triazole hydrazones as new anticonvulsant agents. Bioorg Chem 78:119\u2013129. \nhttps:\/\/doi.org\/10.1016\/j.bioorg.2018.03.001","journal-title":"Bioorg Chem"},{"key":"9940_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejmech.2016.01.054","volume":"112","author":"M Mohammadi-Khanaposhtani","year":"2016","unstructured":"Mohammadi-Khanaposhtani M, Shabani M, Faizi M, Aghaei I, Jahani R, Sharafi Z, Zafarghandi NS, Mahdavi M, Akbarzadeh T, Emami S, Shafiee A (2016) Design, synthesis, pharmacological evaluation, and docking study of new acridone-based 1,2,4-oxadiazoles as potential anticonvulsant agents. Eur J Med Chem 112:91\u201398. \nhttps:\/\/doi.org\/10.1016\/j.ejmech.2016.01.054","journal-title":"Eur J Med Chem"},{"key":"9940_CR20","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1016\/j.ejmech.2011.09.021","volume":"46","author":"HI El-Subbagh","year":"2011","unstructured":"El-Subbagh HI, Hassan GS, El-Azab AS, Alaa AM, Kadi AA, Al-Obaid AM, Al-Shabanah OA, Sayed-Ahmed MM (2011) Synthesis and anticonvulsant activity of some new thiazolo[3,2-a][1,3]diazepine, benzo[d]thiazolo[5,2-a][12,6]diazepine and benzo[d]oxazolo[5,2-a][12,6]diazepine analogues. Eur J Med Chem 46:5567\u20135572. \nhttps:\/\/doi.org\/10.1016\/j.ejmech.2011.09.021","journal-title":"Eur J Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-019-09940-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11030-019-09940-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-019-09940-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T20:20:59Z","timestamp":1584562859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11030-019-09940-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["9940"],"URL":"https:\/\/doi.org\/10.1007\/s11030-019-09940-9","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,20]]},"assertion":[{"value":"29 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}